Drugmaker Pfizer starts low with 2023 earnings forecastPfizer surprised Wall Street on Tuesday by predicting bigger-than-expected sales drops this year for two key products: its COVID-19 vaccine and treatment.
Moderna sues Pfizer, BioNTech over COVID-19 vaccine patentsCOVID-19 vaccine maker Moderna is suing its main competitors Pfizer and the German drugmaker BioNTech.
Pfizer requests emergency use authorization for COVID vaccine in childrenItโs a move that has been highly anticipated by pediatricians and many parents as coronavirus cases have risen in that age group.
Pfizer officially requests FDA emergency use authorization of COVID vaccine in kids 5-11Pfizer and BioNTech have officially submitted a request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization of their COVID-19 vaccine for children aged 5 to 11.
Pfizer submits data to FDA as it seeks to use COVID vaccine in children aged 5-11Pfizer Inc.and BioNTech announced Tuesday they have submitted data to the U.S. Food and Drug Administration (FDA) from the Phase 2/3 trial of their COVID-19 vaccine in children 5 to 12 years of age.
Pfizer submits data to FDA as it seeks to use COVID vaccine in children aged 5-11Pfizer plans to request Emergency Use Authorization from the FDA for this age group to receive the vaccine in the coming weeks.
Can COVID patients donate organs? Are face masks bad for your health?Since the coronavirus pandemic began, Dr. Frank McGeorge has been keeping viewers up-to-date and informed on all fronts.
CDC vaccine advisory panel focuses on full FDA approval of Pfizerโs COVID vaccineThe CDCโs vaccine advisory panel held a public meeting on Monday and discussed the recent full FDA approval of Comirnaty, Pfizerโs COVID vaccine.
Pfizerโs COVID-19 vaccine โComirnatyโ receives full approval from FDAOn Monday, the U.S. Food and Drug Administration gave full approval to the Pfizer-BioNTech COVID-19 Vaccine, which will now be marketed as Comirnaty.